Page 13 - Boxed Warning News Today

/PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that five new presentations related to Peyronies disease, or PD, and XIAFLEX® (collagenase...

Likmez, a ready-to-use oral suspension of metronidazole, has been made available by Kesin Pharma Corporation.

NEW YORK, Nov. 15, 2023 /PRNewswire/ -- Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the...

/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and...

ROCKVILLE, Md. & EDMONTON, Alberta, November 13, 2023--Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug Application (NDA) for LUPKYNIS® (Voclosporin) in Japan

FDA approves a new weight loss drug, Zepbound, from Eli Lilly. Here’s what you should know.

Representation is important across all fields, but especially in healthcare. One area where diverse doctors and nurses are vital is plastic surgery.

The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults aged 18 years and older.

Adults taking Zepbound in a clinical trial lost on average 48 lb. at the highest dose Zepbound is the first and only approved treatment activating two incre ...

The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults aged 18 years and older.